These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 21130128)

  • 1. A novel mechanism of non-Aβ component of Alzheimer's disease amyloid (NAC) neurotoxicity. Interplay between p53 protein and cyclin-dependent kinase 5 (Cdk5).
    Kaźmierczak A; Czapski GA; Adamczyk A; Gajkowska B; Strosznajder JB
    Neurochem Int; 2011 Feb; 58(2):206-14. PubMed ID: 21130128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid-ß promotes neurotoxicity by Cdk5-induced p53 stabilization.
    Lapresa R; Agulla J; Sánchez-Morán I; Zamarreño R; Prieto E; Bolaños JP; Almeida A
    Neuropharmacology; 2019 Mar; 146():19-27. PubMed ID: 30452955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. alpha-Synuclein enhances secretion and toxicity of amyloid beta peptides in PC12 cells.
    Kazmierczak A; Strosznajder JB; Adamczyk A
    Neurochem Int; 2008 Dec; 53(6-8):263-9. PubMed ID: 18804502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular alpha-synuclein induces calpain-dependent overactivation of cyclin-dependent kinase 5 in vitro.
    Czapski GA; Gąssowska M; Wilkaniec A; Cieślik M; Adamczyk A
    FEBS Lett; 2013 Sep; 587(18):3135-41. PubMed ID: 23954626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of cyclin-dependent kinase 5 and p53 by ERK1/2 pathway in the DNA damage-induced neuronal death.
    Lee JH; Kim KT
    J Cell Physiol; 2007 Mar; 210(3):784-97. PubMed ID: 17117479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-acetylcysteine prevents beta-amyloid toxicity by a stimulatory effect on p35/cyclin-dependent kinase 5 activity in cultured cortical neurons.
    Hsiao YH; Chen PS; Yeh SH; Lin CH; Gean PW
    J Neurosci Res; 2008 Sep; 86(12):2685-95. PubMed ID: 18512759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of mitofusin 2 links beta-amyloid-mediated mitochondrial fragmentation and Cdk5-induced oxidative stress in neuron cells.
    Park J; Choi H; Min JS; Kim B; Lee SR; Yun JW; Choi MS; Chang KT; Lee DS
    J Neurochem; 2015 Mar; 132(6):687-702. PubMed ID: 25359615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pycnogenol protects neurons from amyloid-beta peptide-induced apoptosis.
    Peng QL; Buz'Zard AR; Lau BH
    Brain Res Mol Brain Res; 2002 Jul; 104(1):55-65. PubMed ID: 12117551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changes of cdk5, p35 and p53 gene expression levels in arsenic-induced neural cell apoptosis].
    Li X; Zhang HM; Niu Q; Yuan FS
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2012 Feb; 30(2):85-8. PubMed ID: 22801079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deregulated Cdk5 promotes oxidative stress and mitochondrial dysfunction.
    Sun KH; de Pablo Y; Vincent F; Shah K
    J Neurochem; 2008 Oct; 107(1):265-78. PubMed ID: 18691386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stabilization and activation of p53 induced by Cdk5 contributes to neuronal cell death.
    Lee JH; Kim HS; Lee SJ; Kim KT
    J Cell Sci; 2007 Jul; 120(Pt 13):2259-71. PubMed ID: 17591690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cdk5-Foxo3 axis: initially neuroprotective, eventually neurodegenerative in Alzheimer's disease models.
    Shi C; Viccaro K; Lee HG; Shah K
    J Cell Sci; 2016 May; 129(9):1815-1830. PubMed ID: 28157684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the E2F-1/p53/Bax pathway by tauroursodeoxycholic acid in amyloid beta-peptide-induced apoptosis of PC12 cells.
    Ramalho RM; Ribeiro PS; Solá S; Castro RE; Steer CJ; Rodrigues CM
    J Neurochem; 2004 Aug; 90(3):567-75. PubMed ID: 15255934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of Id1/HIF-1 and CDK5/HIF-1 in cell cycle reentry induced by amyloid-beta peptide in post-mitotic cortical neuron.
    Chao AC; Chen CH; Wu MH; Hou BY; Yang DI
    Biochim Biophys Acta Mol Cell Res; 2020 Apr; 1867(4):118628. PubMed ID: 31884068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-diabetes drug pioglitazone ameliorates synaptic defects in AD transgenic mice by inhibiting cyclin-dependent kinase5 activity.
    Chen J; Li S; Sun W; Li J
    PLoS One; 2015; 10(4):e0123864. PubMed ID: 25875370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective effect of TNFalpha against the beta-amyloid neurotoxicity mediated by CDK5 kinase.
    Orellana DI; Quintanilla RA; Maccioni RB
    Biochim Biophys Acta; 2007 Feb; 1773(2):254-63. PubMed ID: 17150266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of CDK5/P25 formation/inhibition in neurodegeneration.
    Camins A; Verdaguer E; Folch J; Canudas AM; Pallàs M
    Drug News Perspect; 2006 Oct; 19(8):453-60. PubMed ID: 17160145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cdk5 phosphorylates p53 and regulates its activity.
    Zhang J; Krishnamurthy PK; Johnson GV
    J Neurochem; 2002 Apr; 81(2):307-13. PubMed ID: 12064478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective cytotoxicity of intracellular amyloid beta peptide1-42 through p53 and Bax in cultured primary human neurons.
    Zhang Y; McLaughlin R; Goodyer C; LeBlanc A
    J Cell Biol; 2002 Feb; 156(3):519-29. PubMed ID: 11815632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of Cdk5-mediated Drp1 phosphorylation in Aβ
    Guo MY; Shang L; Hu YY; Jiang LP; Wan YY; Zhou QQ; Zhang K; Liao HF; Yi JL; Han XJ
    J Cell Biochem; 2018 Jun; 119(6):4815-4825. PubMed ID: 29345339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.